Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colm Morrissey

Showing results (151-160 of 170) with videos related to

Pageof 17
Sort By:
Molecular Cancer Research : MCR|May 26, 2026
Integrative Surface Antigen Profiling of KLK2 and STEAP1 in Advanced Prostate CancerErolcan Sayar, Helen M Richards, Roman Gulati, et al.
The Journal of Pathology|October 18, 2023
Characterization of HOXB13 expression patterns in localized and metastatic castration-resistant prostate cancerRadhika A Patel, Erolcan Sayar, Ilsa Coleman, et al.
NPJ Precision Oncology|May 17, 2024
Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlatesAzra Ajkunic, Erolcan Sayar, Martine P Roudier, et al.
Cancer Research Communications|August 6, 2025
Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted TherapiesHyun Jung Lee, Roman Gulati, Erolcan Sayar, et al.
Nature Communications|May 13, 2022
MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targetsXintao Qiu, Nadia Boufaied, Tarek Hallal, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 8, 2022
The Movember Global Action Plan 1 (GAP1): Unique Prostate Cancer Tissue Microarray ResourceVéronique Ouellet, Andrew Erickson, , et al.
Signal Transduction and Targeted Therapy|July 25, 2024
CDC7 inhibition impairs neuroendocrine transformation in lung and prostate tumors through MYC degradationAlvaro Quintanal-Villalonga, Kenta Kawasaki, Esther Redin, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2024
Single-cell analysis of treatment-resistant prostate cancer: Implications of cell state changes for cell surface antigen-targeted therapiesSamir Zaidi, Jooyoung Park, Joseph M Chan, et al.
Cancer Discovery|November 18, 2022
Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer PhenotypesNavonil De Sarkar, Robert D Patton, Anna-Lisa Doebley, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
CHIMERA-DDR: A Machine Learning Framework for Classifying Heterogeneous Mismatch-Repair and Homologous-Recombination Deficiency Patterns in Prostate CancerKomal Sharma, Divin A Wilson, Yu Wang, et al.
Pageof 17

Showing results (151-160 of 170) with videos related to

Sort By:
Pageof 17
Molecular Cancer Research : MCR|May 26, 2026
Integrative Surface Antigen Profiling of KLK2 and STEAP1 in Advanced Prostate CancerErolcan Sayar, Helen M Richards, Roman Gulati, et al.
The Journal of Pathology|October 18, 2023
Characterization of HOXB13 expression patterns in localized and metastatic castration-resistant prostate cancerRadhika A Patel, Erolcan Sayar, Ilsa Coleman, et al.
NPJ Precision Oncology|May 17, 2024
Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlatesAzra Ajkunic, Erolcan Sayar, Martine P Roudier, et al.
Cancer Research Communications|August 6, 2025
Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted TherapiesHyun Jung Lee, Roman Gulati, Erolcan Sayar, et al.
Nature Communications|May 13, 2022
MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targetsXintao Qiu, Nadia Boufaied, Tarek Hallal, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 8, 2022
The Movember Global Action Plan 1 (GAP1): Unique Prostate Cancer Tissue Microarray ResourceVéronique Ouellet, Andrew Erickson, , et al.
Signal Transduction and Targeted Therapy|July 25, 2024
CDC7 inhibition impairs neuroendocrine transformation in lung and prostate tumors through MYC degradationAlvaro Quintanal-Villalonga, Kenta Kawasaki, Esther Redin, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2024
Single-cell analysis of treatment-resistant prostate cancer: Implications of cell state changes for cell surface antigen-targeted therapiesSamir Zaidi, Jooyoung Park, Joseph M Chan, et al.
Cancer Discovery|November 18, 2022
Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer PhenotypesNavonil De Sarkar, Robert D Patton, Anna-Lisa Doebley, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
CHIMERA-DDR: A Machine Learning Framework for Classifying Heterogeneous Mismatch-Repair and Homologous-Recombination Deficiency Patterns in Prostate CancerKomal Sharma, Divin A Wilson, Yu Wang, et al.
Pageof 17